55
Views
5
CrossRef citations to date
0
Altmetric
Brief Communications

Clonal spread of Klebsiella pneumoniae producing KPC-2 beta-lactamase in Croatian University Hospital

, , , , , , & show all

References

  • Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2007;2:501–12.
  • Canton R, Akowa M, Carmely Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18:413–31.
  • Yigit H, Quennan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151–61.
  • Naas T, Vandel W, Sougakoff W, Livermore DM, Nordmann P. Cloning and sequence analysis of the gene for carbapenem hydrolyzing class A beta-lactamase, SME-1 from Serratia marcescens S6. Antimicrob Agents Chemother. 1994;38:1262–70.
  • Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase of Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother. 1993;37:939–46.
  • Prottumarthy S, Moland ES, Jeretschko S, Swanzy R, Thomson KS, Fritsche TR. NMC-A carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerging Infect Dis. 2003;9:999–1002.
  • Yan JJ, Ko WC, Tsai SH, Wu HM, Wu JJ. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a University Medical Center in Taiwan. J Clin Microbiol. 2001;39:4433–9.
  • Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miringou V, Kontou S. VIM-1 Metallo-β-lactamase-producing Klebsiella pnuemoniae strains in Greek hospital. J Clin Microbiol. 2003;41(8):3893–6.
  • Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerging Infect Dis. 2011;17:103–6.
  • Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48 persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy. 2008;54:101–6.
  • Gulmez D, Woodford N, Palepou MF, Mushtag S, Metan G, Yakopogulklan Y, et al. Carbapenem resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48 like carbapenemase and outer membrane protein loss. Int J Antimicrob Agents. 2008;31:523–6.
  • Elliot E, Brink AJ, Van Greune J, Els Z, Woodford N, Turton J. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis. 2006;42:95–8.
  • Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother. 1997;41:563–9.
  • Mazzariol A, Bošnjak Z, Ballarini P, Budimir A, Bedenić B, Kalenić S, et al. NDM-1 producing Klebsiella pneumoniae, Croatia. Emerging Infect Dis. 2012;18(3):532–4.
  • Bedenić B, Mazzariol A, Plečko V, Bošnjak Z, Barl P, Vraneš J, et al. First report of KPC-producing Klebsiella pneumoniae in Croatia. J Chemother. 2012;24:237–9.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. Approved standard MS100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
  • Lee K, Lim YS, Yong D, YUM JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA-double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003;41:4623–9.
  • Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. A sensitive screening test for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47:1631–9.
  • Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867–78.
  • Tan TT, Yong-Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother. 2009;53:146–9.
  • Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V, editor. Antibiotics in laboratory medicine, 2nd edn. Baltimore, MD: Williams and Wilkins; 1986. p. 683–721.
  • Matthew MA, Harris AM, Marshall MJ, Ross GW. The use of isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol. 1975;88:169–78.
  • Nüesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996;15:398–402.
  • Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH. Molecular characterization by PCR restriction fragment polymorphism of TEM β-lactamases. FEMS Microbiol Lett. 1995;134:203–8.
  • Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004;54:735–43.
  • Woodford N, Zhang J, Warner M, Kaufmann ME, Matos J, Macdonald A, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother. 2008;62:1261–4.
  • Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153–62.
  • Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother. 2006;57:154–5.
  • Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, Ould-Hocine Z, et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett. 2002;209:161–8.
  • Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6:629–40.
  • Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae from United States. Antimicrob Agents Chemother. 2006;50:2872–4.
  • Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–28.
  • Kaufman ME. Pulsed-field gel electrophoresis. In: Woodfor N, Johnsons A, editors. Molecular bacteriology. Protocols and clinical applications, 1st edn. New York, NY: Humana Press; 1998. p. 33–51.
  • Grisold A, Zarfel G, Strenger V, et al. Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks. J Infect. 2010;60:44–51.
  • Zujić-Atalić V, Bedenić B, Kocsis E, Mazzariol A, Sardelić S, Barišić M, et al. Diversity of carbapenemases in clinical isolates of Enterobacteriaceae in Croatia-the results of the multicenter study. Clin Microbiol Infect. 2014 [Epub ahead of print].
  • Baboue B, Widmer AF, Dubuis Q, Ciardo D, Droz S, Betsch Y, et al. Emergence of four cases of KPC-2 and KPC-3 producing Klebsiella pneumoniae, introduced to Switzerland 2009–2010. Euro Surveill. 2011;16 (11):16–9.
  • Navon-Venezia S, Chmeltnisky I, Leavitt A, Schwaber MJ, Carmely Y. Plasmid-mediated imipenem hydrolyzing enzyme KPC-2 among carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50:3098–101.
  • Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother. 2007;52:796–7.
  • Steinmann I, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, et al. Outbreak due to a Klebsiella pneumoniae strain KPC-2 and VIM-1 in a German University hospital, July 2010 to January 2011. Euro Surveill. 2011;16 (33):13–8
  • Bogaerts P, Montasinos I, Rodriguez-Villabos H, Blairon L, Deplano A, Glupczinsky Y. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258-producing KPC-2 β-lactamase in Belgium. J Antimicrob Chemother. 2010;65:361–76.
  • Richter S, Frasson I, Bergo C, Parisi C, Cavallaro A, Palu G. Transfer of KPC-2 β-lactamase from Klebsiella pneumoniae to Escherichia coli in a patient: the first case in Europe. J Clin Microbiol. 2011;49:2040–2.
  • Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. First report of Klebsiella oxytoca strains coproducing KPC-2 and IMP-8 carbapenemases. Antimicrob Agents Chemother. 2011;55:2937–41.
  • Woodford N, Tierno PM, Young K, Tysal M, Palepou E, Ward R, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem hydrolyzing class A β-lactamase KPC-3 in a New York Medical Center. Antimicrob Agents Chemother. 2004;48:4793–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.